Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1990 Oct;82(1):75-80.
doi: 10.1111/j.1365-2249.1990.tb05406.x.

Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease

Affiliations
Comparative Study

Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease

Y R Mahida et al. Clin Exp Immunol. 1990 Oct.

Abstract

Plasma and tissue interleukin-2 receptor (IL-2R) levels were determined in patients with active ulcerative colitis and Crohn's disease. Compared with healthy controls (median 440 U/ml; range 240-900), significantly higher levels of plasma IL-2R were present in patients with active ulcerative colitis (median 1180 U/ml; range 580-7150; P less than 0.002) and Crohn's disease (median 1340 U/ml; range 480-9000; P less than 0.002). Compared with other laboratory parameters, plasma IL-2R levels were related most closely to clinical score of disease activity in Crohn's disease. Plasma IL-2R levels also reflected the clinical course and may provide a more accurate assessment of disease activity in Crohn's disease. In plasma of patients undergoing intestinal resection of active inflammatory bowel disease, raised levels of IL-2R were present in samples from mesenteric vein (draining inflamed intestine) compared with those from peripheral vein. In tissue homogenates of colonic biopsies, significantly higher levels of IL-2R were present in specimens from colons with active ulcerative colitis compared with healthy controls (median 230.2, range 20.7-581.5 versus 77.9, range 34.2-291.3; P less than 0.02).

PubMed Disclaimer

Similar articles

Cited by

References

    1. Scand J Gastroenterol. 1978;13(7):833-7 - PubMed
    1. Lancet. 1980 Mar 8;1(8167):514 - PubMed
    1. Gastroenterology. 1984 Apr;86(4):734-42 - PubMed
    1. J Clin Pathol. 1984 Sep;37(9):1027-8 - PubMed
    1. Clin Immunol Immunopathol. 1984 Nov;33(2):232-44 - PubMed

Publication types